Options: Relapsed and refractory non-Hodgkin's lymphoma

被引：0
|
作者：
Friedberg, Jonathan W. [1 ]
机构：
[1] Univ Rochester, Wilmot Canc Ctr, Rochester, NY USA
来源：
CANCER INVESTIGATION | 2007年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：36 / 37
页数：2
相关论文
共 50 条
  • [21] Allogeneic bone marrow transplantation for relapsed and refractory Hodgkin's disease and non-Hodgkin's lymphoma
    Dann, EJ
    Daugherty, CK
    Larson, RA
    [J]. BONE MARROW TRANSPLANTATION, 1997, 20 (05) : 369 - 374
  • [22] A multicenter phase II study of darinaparsin in relapsed or refractory Hodgkin's and non-Hodgkin's lymphoma
    Hosein, Peter J.
    Craig, Michael D.
    Tallman, Martin S.
    Boccia, Ralph V.
    Hamilton, Brian L.
    Lewis, Jonathan J.
    Lossos, Izidore S.
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2012, 87 (01) : 111 - 114
  • [23] Allogeneic bone marrow transplantation for relapsed and refractory Hodgkin’s disease and non-Hodgkin’s lymphoma
    EJ Dann
    CK Daugherty
    RA Larson
    [J]. Bone Marrow Transplantation, 1997, 20 : 369 - 374
  • [24] Gemcitabine as single agent in the treatment of relapsed and refractory Hodgkin's and non-Hodgkin lymphoma.
    Jajeh, A
    Hadad, L
    Zalzaleh, G
    Ruestow, P
    [J]. BLOOD, 2003, 102 (11) : 285B - 285B
  • [25] Zanubrutinib monotherapy in relapsed/refractory indolent non-Hodgkin lymphoma
    Phillips, Tycel
    Chan, Henry
    Tam, Constantine S.
    Tedeschi, Alessandra
    Johnston, Patrick
    Oh, Sung Yong
    Opat, Stephen
    Eom, Hyeon-Seok
    Allewelt, Heather
    Stern, Jennifer C.
    Tan, Ziwen
    Novotny, William
    Huang, Jane
    Trotman, Judith
    [J]. BLOOD ADVANCES, 2022, 6 (11) : 3472 - 3479
  • [26] Bendamustine, vincristine, prednisolone in relapsed and refractory low grade non-Hodgkin's lymphoma
    Kath, R
    Blumenstengel, K
    Fricke, HJ
    Peters, HD
    Höffken, K
    [J]. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2001, 126 (08) : 198 - 202
  • [27] Pixantrone in relapsed or refractory aggressive non-Hodgkin’s lymphoma: a guide to its use
    Keating G.M.
    Lyseng-Williamson K.A.
    [J]. Drugs & Therapy Perspectives, 2017, 33 (4) : 160 - 166
  • [28] Gemcitabine as a single agent in the treatment of relapsed or refractory aggressive non-Hodgkin's lymphoma
    Fosså, A
    Santoro, A
    Hiddemann, W
    Truemper, L
    Niederle, N
    Buksmaui, S
    Bonadonna, G
    Seeber, S
    Nowrousian, MR
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (12) : 3786 - 3792
  • [29] Lenalidomide oral monotherapy in relapsed/refractory small lymphocytic non-Hodgkin's lymphoma
    Witzig, T. E.
    Vose, J. M.
    Justice, G.
    Kaplan, H. G.
    Reeder, C. B.
    Pietronigro, D.
    Takeshita, K.
    Ervin-Haynes, A.
    Zeldis, J. B.
    Wiernik, P. H.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [30] A Population Pharmacokinetic and Pharmacodynamic Evaluation of Pralatrexate in Patients With Relapsed or Refractory Non-Hodgkin's or Hodgkin's Lymphoma
    Mould, D. R.
    Sweeney, K.
    Duffull, S. B.
    Neylon, E.
    Hamlin, P.
    Horwitz, S.
    Sirotnak, F.
    Fleisher, M.
    Saunders, M. E.
    O'Connor, O. A.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2009, 86 (02) : 190 - 196
12345